A U.S. FDA safety review has resulted in adding warnings to the labels of a specific class of type 2 diabetes medicines …
Oral Medication
Invokana Warning: Diabetes Drug May Increase Risk of Bone Fractures
Several months ago the FDA warned that SGLT2 inhibitors like Invokana may cause diabetic ketoacidosis, a condition that …
The Novo Nordisk Pipeline: An Interview with CMO Todd Hobbs
Todd Hobbs, the chief medical officer for North America at Novo Nordisk, knows diabetes from all angles: as a patient; a…
Do SGLT2 Inhibitors like Invokana Cause Ketoacidosis?
Only a tiny number of cases of diabetic ketoacidosis have been reported with SGLT2 inhibitor treatment, so this is unlik…
FDA Approves Glyxambi, New Type 2 Diabetes Medication
The U.S. Food and Drug Administration (FDA) has approved Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company’…
Invokana Helps My Type 1 Diabetes
I emailed my endo ahead of time to give her a heads up that I wanted to discuss going on Invokana. Unfortunately, she wa…
Using Type 2 Diabetes Medication to Treat Type 1 Diabetes
There have been a number of new developments in the treatment of type 2 diabetes, and a question often asked is whether …
FDA Issues Complete Response Letter for Type 2 Diabetes Drug Empagliflozin
The FDA has issued a complete response letter to Boehringer Ingelheim and Eli Lilly for the New Drug Application (NDA) …
Type 2 Diabetes Treatments May Benefit People with Type 1 Diabetes
The change in thinking about the ways type 2 diabetes evolves indirectly opened the door to considering new ways of thin…
FDA to Review Data Regarding Saxagliptin Use and Increased Risk of Heart Failure
The FDA has requested clinical trial data from the manufacturer of saxagliptin, Bristol-Myers Squibb and AstraZeneca, to…